Effects of Pamidronate on Dental Enamel Formation Assessed by Light Microscopy, Energy-Dispersive X-Ray Analysis, Scanning Electron Microscopy, and Microhardness Testing

被引:3
作者
Soares, Ana P. [1 ]
do Espirito Santo, Renan F. [2 ]
Line, Sergio R. P. [3 ]
Pinto, Maria das G. F. [4 ]
Santos, Pablo de M. [5 ]
Toralles, Maria Betania P. [6 ]
do Espirito Santo, Alexandre R. [6 ]
机构
[1] Fed Univ Bahia UFBA, Multidisciplinary Inst Hlth, Rua Rio Contas 58,Quadra 17,Lote 58, BR-45029094 Vitoria Da Conquista, BA, Brazil
[2] Fed Univ Bahia UFBA, Fac Pharm, Rua Barao Jeremoabo S-N,Campus Univ Ondina, BR-40170115 Salvador, BA, Brazil
[3] Univ Campinas UNICAMP, Piracicaba Dent Sch, Ave Limeira 901, BR-13414903 Piracicaba, SP, Brazil
[4] Fed Univ Bahia UFBA, Sch Vet Med & Zootechny, Ave Ademar Barros 500, BR-40170110 Salvador, BA, Brazil
[5] Fed Univ Bahia UFBA, Prof Edgard Santos Univ Hosp, Rua Augusto Viana S-N, BR-40110060 Salvador, BA, Brazil
[6] Fed Univ Bahia UFBA, Inst Hlth Sci, Ave Reitor Miguel Calmon S-N, BR-40110902 Salvador, BA, Brazil
关键词
bisphosphonates; enamel; light microscopy; scanning electron microscopy; microanalysis; SEVERE OSTEOGENESIS IMPERFECTA; BISPHOSPHONATES MECHANISMS; SECRETORY AMELOBLASTS; 1-BISPHOSPHONATE HEBP; SUCCESSIVE INJECTIONS; CHILDREN; INCISORS; 1-HYDROXYETHYLIDENE-1,1-BISPHOSPHONATE; OSTEOPOROSIS; MATRIX;
D O I
10.1017/S1431927616000726
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The aim of the present work was to investigate birefringence and morphology of the secretory-stage enamel organic extracellular matrix (EOECM), and structural and mechanical properties of mature enamel of upper incisors from adult rats that had been treated with pamidronate disodium (0.5 mg/kg/week for 56 days), using transmitted polarizing and bright-field light microscopies (TPLM and BFLM), energy-dispersive X-ray (EDX) analysis, scanning electron microscopy (SEM) and microhardness testing. BFLM showed no morphological changes of the EOECM in pamidronate and control groups, but TPLM revealed a statistically significant reduction in optical retardation values of birefringence brightness of pamidronate-treated rats when compared with control animals (p<0.01). EDX analysis showed that pamidronate-induced statistically significant decrease in phosphorus' quantity in outer mature enamel (p<0.01) and an increase in the calcium/phosphorus ratio in that structure (p<0.05). Pamidronate did not induce ultra-structural alterations in mature enamel as revealed by SEM and did not cause a reduction in its microhardness (p>0.05). The present study indicates that pamidronate can affect birefringence of the secretory-stage EOECM, which does not seem to be associated with significant changes in morphological and/or mechanical properties of mature enamel.
引用
收藏
页码:640 / 648
页数:9
相关论文
共 46 条
[1]   The Use of Zoledronic Acid in Pediatric Cancer Patients [J].
August, Keith J. ;
Dalton, Amanda ;
Katzenstein, Howard M. ;
George, Bradley ;
Olson, Thomas A. ;
Wasilewski-Masker, Karen ;
Rapkin, Louis B. .
PEDIATRIC BLOOD & CANCER, 2011, 56 (04) :610-614
[2]   Clinical Review: Bisphosphonate Use in Childhood Osteoporosis [J].
Bachrach, Laura K. ;
Ward, Leanne M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) :400-409
[3]   Intravenous pamidronate therapy in osteogenesis imperfecta - Response to treatment and factors influencing outcome [J].
Bajpai, Anurag ;
Kabra, Madhulika ;
Gupta, Neerja ;
Sharda, Sheetal ;
Ghosh, Manju .
JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2007, 27 (02) :225-227
[4]   The Use of Bisphosphonates in Pediatrics [J].
Baroncelli, Giampiero I. ;
Bertelloni, Silvano .
HORMONE RESEARCH IN PAEDIATRICS, 2014, 82 (05) :290-302
[5]   Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta [J].
Barros, Elizabete Ribeiro ;
Saraiva, Gabriela L. ;
de Oliveira, Telma Palomo ;
Lazaretti-Castro, Marise .
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2012, 25 (5-6) :485-491
[6]  
Bartlett JD, 2013, ISRN DENT, V2013
[7]   Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial [J].
Bishop, Nick ;
Adami, Silvano ;
Ahmed, S. Faisal ;
Anton, Jordi ;
Arundel, Paul ;
Burren, Christine P. ;
Devogelaer, Jean-Pierre ;
Hangartner, Thomas ;
Eva Hosszu ;
Lane, Joseph M. ;
Lorenc, Roman ;
Makitie, Outi ;
Munns, Craig F. ;
Paredes, Ana ;
Pavlov, Helene ;
Plotkin, Horacio ;
Raggio, Cathleen L. ;
Loreto Reyes, Maria ;
Schoenau, Eckhard ;
Semler, Oliver ;
Sillence, David O. ;
Steiner, Robert D. .
LANCET, 2013, 382 (9902) :1424-1432
[8]   Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review [J].
Castillo, Heidi ;
Samson-Fang, Lisa .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2009, 51 (01) :17-29
[9]   Complications of pamidronate therapy in paediatric osteoporosis [J].
Chilbule, Sanjay K. ;
Madhuri, Vrisha .
JOURNAL OF CHILDRENS ORTHOPAEDICS, 2012, 6 (01) :37-43
[10]   Pharmacology of bisphosphonates [J].
Cremers, Serge ;
Papapoulos, Socrates .
BONE, 2011, 49 (01) :42-49